Science and Deeptech

Commercialization Company.

We conceptualise and Co-Build deeptech companies with scientific entrepreneurs and inventive engineers, ‍

‍unlock new pathways and shape systems for breakthrough science to diffuse from labs to lives.

Science and Deeptech

Commercialization Company.

We conceptualise and Co-Build deeptech companies with scientific entrepreneurs and inventive engineers, unlock new pathways and shape systems for breakthrough science to diffuse from labs to lives.

The Problem

Why breakthrough science doesn’t break through to society?

1. Breakthroughs Are Happening Everywhere
‍We are living in an invention era, across the globe, powerful advances are emerging — in AI, quantum labs, biotech clusters, space-tech, and advanced materials.

2. But They Get Stuck in the Labs or In Sandboxes
‍Most of these breakthroughs remain trapped in academic silos, stalled at the prototype stage, or lost in translation — taking years, even decades, to reach real-world use.

3. The Journey from Invention to Impact and Markets is inefficient 
‍It’s not because science and technology is flawed or not ready.  It’s because the systems that translate breakthroughs into ventures for meaningful societal impact are missing and have to be rethought for this new age of accelerated discovery. 
‍ 
4. Founders Face Chasms and Unchartered Seas
‍Scientific entrepreneurs and inventive engineers often stand at the edge of a vast gaps — with misaligned incentives for commercialisation in academia, no clear and efficient pathways for scientific venture creation, and  early stage deeptech oriented partners  to help them build world redefining ventures.

5. We need redesigned pathways for Deeptech and Science Ventures
‍There’s no shortage of discovery and invention. What’s missing is the ability, systems and efficient pathways to turn more of that science into something  society can use, fund, and scale.

Challenges

The challenges show up in five critical gaps — the missing pieces that stop more science and deeptech from reaching the world.

Missing Translational
Innovation

Deeptech often advances in labs, but the critical step of developing real-world use cases and shaping them into scalable products is neglected, stalling impact.

Misaligned
Capital Structures

Science and deeptech needs patient capital that needs to be infused differently..Models build for the internet and software worlds cannot be expected to work efficiently for this new technological wave.

Distance from Societal Needs and Industry Realities

Technologies are often developed in isolation, without being shaped by the people and places they aim to serve.

Complex and Technical Narratives - Communication

Scientific and deeptech potential and complexity isn’t communicated in ways that engage customers and markets or align with societal needs.

Inaccessible
Infrastructure

Limited access to testing grounds, lab setups, prototyping and manufacturing support, or launch environments for deep science and emerging technologies.

Mission

Unusual. exists to solve these challenges.

Our mission is to build systems and pathways to help scientific entrepreneurs take breakthroughs from labs to society for human progress .

Pathways of Unusual

Our approaches to unleashing deep tech innovation

Speculative product drops to tell stories that matter about science - tech and society.
A whole new way to conceptualise, co-build and de-risk early-stage deeptech ventures through in-the-trenches collaboration.

Pathways of Unusual

Our approaches to unleashing deep tech innovation

Speculative product drops to tell stories that matter about science - tech and society.
A whole new way to conceptualise, co-build and de-risk early-stage deeptech ventures through in-the-trenches collaboration.

portfolio

Companies Backed by Unusual. 

RapidX
‍
World’s Fastest Molecular Diagnostic Platform.
→
InSilicoMinds

Accelerates drug development with AI-driven modeling and simulation.
→
Upcoming Venture

Our next venture is currently in stealth—stay tuned.

portfolio

Companies Backed by Unusual. 

RapidX
‍
Enables 10-minute, portable disease diagnostics.
→
InSilicoMinds

Accelerates drug development with AI-driven modeling and simulation.
→
Upcoming Venture

Our next venture is currently in stealth—stay tuned.

Let’s build the future of deeptech—together.

Reach out at helloworld@unusual.tech

Subscribe for our latest updates and insights on deeptech ventures.
By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
LinkedIn